Turalio™ (pexidartinib) – New orphan drug approval
August 2, 2019 - The FDA announced the approval of Daiichi Sankyo’s Turalio (pexidartinib), for the treatment of adult patients with symptomatic tenosynovial giant cell tumor (TGCT) associated with severe morbidity or functional limitations and not amenable to improvement with surgery.
Top